Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: infliximab

EULAR 2014: Biosimilar Drug Production Raises Concerns

Thomas R. Collins  |  August 1, 2014

Rheumatology experts question biosimilars’ safety, efficacy given their complex production process

Filed under:Biologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsRheumatoid Arthritis Tagged with:BiosimilarsCollinsdrugEULARinfliximabInternationalRheumatoid arthritisrheumatologistrheumatologySafety

EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis

Thomas R. Collins  |  August 1, 2014

Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:Ankylosing Spondylitisanti-inflammatoryBiologicsCollinsdrugEULARGlucocorticoidsinfliximabInternationalMethotrexateResearchRheumatoid arthritisrheumatologySafety

Malignant Atrophic Papulosis Is Challenging to Diagnose, Treat

Aixa Toledo-Garcia, MD, Jessica Farrell, PharmD, & Lee Shapiro, MD  |  July 1, 2014

Patient histories, clinician reports of condition also called Köhlmeier-Degos disease underscore need for integrated, multidisciplinary care

Filed under:Biologics/DMARDsConditionsDrug UpdatesSystemic Lupus ErythematosusSystemic SclerosisVasculitis Tagged with:Biologicsdruginfliximabintravenous immune globulinpatient carerheumatologistSclerodermasystemic lupus erythematousVasculitis

What’s New in Inflammatory Arthritis?

Thomas R. Collins  |  June 1, 2014

Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesRheumatoid Arthritis Tagged with:AC&RadalimumabAmerican College of Rheumatology (ACR)BiosimilarsCollinsdruginfliximabMethotrexateradiographRheumatoid arthritistocilizumab

New Treatments Needed to Prevent Fractures in Osteoporosis

Ellen M. Field, MD, FACR, CCD  |  June 1, 2014

Current therapies target pathways of bone remodeling, but rheumatologists say a better understanding of the mechanisms of bone resorption, formation is needed to make an impact

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone DisordersRheumatoid Arthritis Tagged with:Biologicsbone remodelingimagingOsteoporosispatient careRheumatoid arthritisrheumatologistUltrasound

7 Things Ophthalmologists Want Rheumatologists to Know

Vanessa Caceres  |  May 1, 2014

Careful collaboration is key to treating patients with rheumatic or inflammatory diseases that affect the eyes

Filed under:Axial SpondyloarthritisCareer DevelopmentConditionsEducation & TrainingProfessional TopicsRheumatoid ArthritisSjögren’s DiseaseSystemic Lupus ErythematosusVasculitis Tagged with:Ankylosing Spondylitisgranulomatosis with polyangiitisLupusmultidisciplinary careocular diseaseOphthalmologistpatient careReactive arthritisRheumatic DiseaseRheumatoid arthritisrheumatologistSjogren'sVasculitis

Fellow’s Forum Case Report: Takayasu’s Arteritis

Ashwini Komarla, MD; Michael George, MD; Antoine Sreih, MD; & Chris Derk, MD, MS  |  May 1, 2014

How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease

Filed under:ConditionsVasculitis Tagged with:drugGiant Cell ArteritisGlucocorticoidsimaginginfliximablarge-vessel vasculitisMethotrexatePainpatient careprednisonerheumatologistrituximabTakayasu’s ArteritistocilizumabTreatmentVasculitis

Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

Atul Deodhar, MD  |  May 1, 2014

New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

Filed under:Axial SpondyloarthritisConditionsResearch Rheum Tagged with:Ankylosing Spondylitisanti-inflammatoryaxial skeletal inflammationaxial spondyloarthritis (SpA)DrugsepidemiologyimagingPainpatient careradiographResearchrheumatologistrituximabterminologyTofacitinib

Exploring Kawasaki Disease

Mary Beth Son, MD  |  April 2, 2014

New epidemiologic data, clinical studies have shed light on diagnosis, treatments, patient outcomes for this childhood disease, but etiology is still unknown

Filed under:Clinical Criteria/GuidelinesConditions Tagged with:ACR/ARHP Annual Meetingimmune intravenous globulininfliximabJuvenile idiopathic arthritisKawasaki diseasepatient carerheumatologist

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  February 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Biologics/DMARDsConditionsDrug UpdatesPain SyndromesRheumatoid Arthritis Tagged with:ApprovalsBiosimilarsdrugFDAFibromyalgiainfliximabPipelineRheumatoid arthritisrheumatologistrheumatologyrituximabSafety

  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 41
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences